It has been approved after a priority review at the FDA, used for drugs that promise to offer a significant improvement on current therapies. In a statement, Lundbeck noted that Rexulti has been ...

Agitated patients are often prescribed antipsychotic medications and sedatives off ... In 2023, Otsuka Pharmaceuticals’ Rexulti (brexpiprazole) became the first FDA-approved treatment for ...

Industry veteran Charmaine Lykins to helm Transneural as it transforms the treatment of neuropsychiatric disorders ISSAQUAH, WASHINGTON / ACCESS Newswire / April 22, 2025 / CaaMTech, Inc. has spun out ...